How to Cite
Abstract
Budd-Chiari syndrome is classified among rare diseases with an incidence of 0.45 per million. Consists of an obstruction to the hepatic venous flow that is due to multiple etiologies, most commonly a venous thrombosis, generating hepatic congestion with increased portal venous pressure thus producing fibrosis and eventually liver failure. Its management is aimed at reversing the obstruction, improving blood flow and perfusion to preserve organ function.
Keywords
References
1. Lupasco I, Dumbrava VT. Diagnosis and therapy of Budd Chiari syndrome. Med Pharm Rep [Internet]. 2021;94(Suppl No 1):S68–71. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/34527916%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8411809
2. Sh. Hassan AA, Alsaleh ME, Alsaleh ME, al Zaher FA, Almajed FA, Alkhudhair AM, et al. Budd-Chiari Syndrome: A Case Report of a Rare Presentation of COVID-19. Cureus. 2021;13(1):7–9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863030/
3. Alukal JJ, Zhang T, Thuluvath PJ. A Nationwide Analysis of Budd–Chiari Syndrome in the United States. J Clin Exp Hepatol [Internet]. 2021;11(2):181–7. Disponible en: https://doi.org/10.1016/j.jceh.2020.08.005
4. Pérez-González A, Argibay A, Lorenzo-Castro R, Martín-Granizo I, Rivera-Gallego A. Budd-Chiari syndrome: epidemiological and clinical characteristics of a case series in Northwest Spain. Egyptian Liver Journal [Internet]. 2022;12(1):1–7. Disponible en: https://doi.org/10.1186/s43066-022-00192-1
5. Iliescu L, Toma L, Mercan-Stanciu A, Grumeza M, Dodot M, Isac T, et al. Budd-Chiari syndrome - various etiologies and imagistic findings. A pictorial review. Med Ultrason. 2019;21(3):344–8. Disponible en: https://doi.org/10.11152/mu-1921
6. Gavriilidis P, Marangoni G, Ahmad J, Azoulay D. State of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review. J Clin Med Res [Internet]. 2022;14(4):147–57. Disponible en: https://www.doi.org/10.14740/jocmr4724
7. Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL) [Internet]. Vol. 15, Hepatology International. Springer India; 2021. 531–567 p. Disponible en: https://doi.org/10.1007/s12072-021-10189-4
8. Hernández-Gea V, de Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol [Internet]. 2019;71(1):175–99. Disponible en: https://doi.org/10.1016/j.jhep.2019.02.015
9. Stanciugelu A, Petrică A, Chiriac SDAN, Iurciuc M, Boruga MV, Balica N, et al. A rare encounter with two cases of Budd Chiari syndrome in the Emergency Department : A case report. Exp Ther Med [Internet]. 2022;24(730):1–5. Disponible en: https://doi.org/10.3892/etm.2022.11666
10. Mancuso A. Budd – Chiari Syndrome Management : Controversies and Open Issues. Diagnostics [Internet]. 2022;12(11). Disponible en: https://www.mdpi.com/2075-4418/12/11/2670#cite
11. Wester A, Åberg F, Rajani R, Hagström H. Minimal risk of hepatocellular carcinoma in non-cirrhotic Budd-Chiari syndrome: A three-decade population-based study. Clinical Gastroenterology and Hepatology [Internet]. 2022;(October):6–9. Disponible en: https://doi.org/10.1016/j.cgh.2022.08.042
12. Aktas H, Ozer A, Yilmaz TU, Keceoglu S, Can MG, Emiroglu R. Liver transplantation for Budd-Chiari syndrome: A challenging but handable procedure. Asian J Surg [Internet]. 2022;45(7):1396–402. Disponible en: https://doi.org/10.1016/j.asjsur.2021.09.007
13. Garmpis N, Damaskos C, Prevezanos D, Garmpi A, Georgakopoulou V, Antoniou E, et al. Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution. MAEDICA – a Journal of Clinical Medicine [Internet]. 2022;17(2):415–9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375878/
14. Das CJ, Soneja M, Tayal S, Chahal A, Srivastava S, Kumar A, et al. Role of radiological imaging and interventions in management of Budd–Chiari syndrome. Clin Radiol [Internet]. 2018;73(7):610–24. Disponible en: https://doi.org/10.1016/j.crad.2018.02.003
15. Artru, Florent. Moschouri, Eleni. Denys Alban. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosistemic shunt (TTIPS) to treat complications of portal hypertension: Indication, technique, and outcomes beyond Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol [Internet]. 2022;46(4):1–16. Disponible en: https://www.sciencedirect.com/science/article/pii/S2210740122000018#section-cited-by
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Array